The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature
Open accessAbstract
This study aimed to elucidate the observed variable phenotypic expressivity associated with NRXN1 (Neurexin 1) haploinsufficiency by analyses of the largest cohort of patients with NRXN1 exonic deletions described to date and by comprehensively reviewing all comparable copy number variants in all disease cohorts that have been published in the peer reviewed literature (30 separate papers in all). Assessment of the clinical details in 25 previously undescribed individuals with NRXN1 exonic deletions demonstrated recurrent phenotypic features consisting of moderate to severe intellectual disability (91%), severe language delay (81%), autism spectrum disorder (65%), seizures (43%), and hypotonia (38%). These showed considerable overlap with previously reported NRXN1 ‐deletion associated phenotypes in terms of both spectrum and frequency. However, we did not find evidence for an association between deletions involving the β‐isoform of neurexin‐1 and increased head size, as was recently published in four cases with a deletion involving the C‐terminus of NRXN1 . We identified additional rare copy number variants in 20% of cases. This study supports a pathogenic role for heterozygous exonic deletions of NRXN1 in neurodevelopmental disorders. The additional rare copy number variants identified may act as possible phenotypic modifiers as suggested in a recent digenic model of neurodevelopmental disorders. © 2013 Wiley Periodicals, Inc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“De novo CNVs are observed in 5%–10% of screened ASD-affected individuals, and after further follow-up studies, some of them have proven to alter high-risk genes (e.g., NRXN112 [MIM 600565]).”
From Convergence of genes and cellular pathways dysregulated in autism spectrum disorders (2014) · cites this paper as [12]
Citations
Cites
Structural Variation of Chromosomes in Autism Spectrum Disorder
Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.009 · Cited by 1,815 · cited 3×
“In addition, several groups have implicated NRXN1 disruption [Kim et al., 2008], point mutations [Marshall et al., 2008; Shah et al., 2010] and genomic deletions in mental retardation (and over-lapping neurodevelopmental phenotypes) [Zahir et al., 2008; Guilmatre et al., 2009; Ching et al., 2010;…”
Rare chromosomal deletions and duplications increase risk of schizophrenia
The International Schizophrenia Consortium (2008) · Nature · doi:10.1038/nature07239 · Cited by 1,475
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
A copy number variation morbidity map of developmental delay
Cooper, G. M., Coe, B. P., Girirajan, S., Rosenfeld, J. A., Vu, T. H., Baker, C., Williams, C., Stalker, H., Hamid, R., Hannig, V., et al. (2011) · Nature Genetics · doi:10.1038/ng.909 · Cited by 1,351
Sanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., Chu, S. H., Moreau, M. P., Gupta, A. R., Thomson, S. A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.002 · Cited by 1,263
CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics
Malhotra, D., & Sebat, J. (2012) · Cell · doi:10.1016/j.cell.2012.02.039 · Cited by 854
A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay
Girirajan, S., Rosenfeld, J. A., Cooper, G. M., Antonacci, F., Siswara, P., Itsara, A., Vives, L., Walsh, T., McCarthy, S. E., Baker, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.534 · Cited by 667
Disruption of neurexin 1 associated with autism spectrum disorder
Kim, H.-G., Kishikawa, S., Higgins, A. W., Seong, I.-S., Donovan, D. J., Shen, Y., Lally, E., Weiss, L. A., Najm, J., Kutsche, K., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.09.011 · Cited by 578
Disruption of the neurexin 1 gene is associated with schizophrenia
Rujescu, D., Ingason, A., Cichon, S., Pietiläinen, O. P. H., Barnes, M. R., Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn351 · Cited by 471
Cited by
Sorted by citations
Convergence of genes and cellular pathways dysregulated in autism spectrum disorders
Pinto, D., Delaby, E., Merico, D., Barbosa, M., Merikangas, A., Klei, L., Thiruvahindrapuram, B., Xu, X., Ziman, R., Wang, Z., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.03.018 · Cited by 969
Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders
Nelson, S. B., & Valakh, V. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.033 · Cited by 1,001
Excess of rare, inherited truncating mutations in autism
Krumm, N., Turner, T. N., Baker, C., Vives, L., Mohajeri, K., Witherspoon, K., Raja, A., Coe, B. P., Stessman, H. A., He, Z.-X., et al. (2015) · Nature Genetics · doi:10.1038/ng.3303 · Cited by 587
Persico, A. M., & Napolioni, V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.012 · Cited by 258
Genetics and epigenetics of autism spectrum disorder—current evidence in the field
Wiśniowiecka‐Kowalnik, B., & Nowakowska, B. (2019) · Journal of Applied Genetics · doi:10.1007/s13353-018-00480-w · Cited by 249
Doherty, J. L., & Owen, M. J. (2014) · Genome Medicine · doi:10.1186/gm546 · Cited by 228
Neurexins: molecular codes for shaping neuronal synapses
Gomez, A. M., Traunmüller, L., & Scheiffele, P. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-00415-7 · Cited by 242
Pak, C., Dankó, T., Zhang, Y., Aoto, J. N., Anderson, G. R., Maxeiner, S., Yi, F., Wernig, M., & Südhof, T. C. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.07.017 · Cited by 227
A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders
Gonzalez-Mantilla, A. J., Moreno-De-Luca, A., Ledbetter, D. H., & Martin, C. L. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2692 · Cited by 139
Comprehensive comparative analysis of 5′-end RNA-sequencing methods
Adiconis, X., Haber, A. L., Simmons, S., Levy‐Moonshine, A., Ji, Z., Busby, M., Shi, X., Jacques, J., Lancaster, M. A., Pan, J. Q., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0014-2 · Cited by 121
Roberts, J., Hovanes, K., Dasouki, M., Manzardo, A. M., & Butler, M. G. (2013) · Gene · doi:10.1016/j.gene.2013.10.020 · Cited by 111
Connor, S. A., Ammendrup-Johnsen, I., Chan, A. W., Kishimoto, Y., Murayama, C., Kurihara, N., Tada, A., Ge, Y., Lu, H., Yan, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.016 · Cited by 100
AMPA Receptors as Therapeutic Targets for Neurological Disorders
Lee, K., Goodman, L., Fourie, C., Schenk, S., Leitch, B., & Montgomery, J. M. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.10.004 · Cited by 106
Lal, D., Ruppert, A., Trucks, H., Schulz, H., de Kovel, C. G. F., Trenité, D. G. A. K.-N., Sonsma, A. C. M., Koeleman, B. P. C., Lindhout, D., Weber, Y. G., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005226 · Cited by 101
Lowther, C., Speevak, M. D., Armour, C. M., Goh, E. S., Graham, G. E., Li, C. C., Zeesman, S., Nowaczyk, M. J. M., Schultz, L., Morra, A., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.54 · Cited by 91
Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders
Hu, Z., Xiao, X., Zhang, Z., & Li, M. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0438-9 · Cited by 99
Tromp, A., Mowry, B. J., & Giacomotto, J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00944-8 · Cited by 100
Control of neural circuit formation by leucine-rich repeat proteins
de Wit, J., & Ghosh, A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.004 · Cited by 97
A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons
Lin, Y., Frei, J. A., Kilander, M. B. C., Shen, W., & Blatt, G. J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00263 · Cited by 97
Overview of Mouse Models of Autism Spectrum Disorders
Bey, A. L., & Jiang, Y. (2014) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0566s66 · Cited by 85
NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families
Shehhi, M. R. A., Forman, E., Fitzgerald, J. E., McInerney, V., Krawczyk, J., Shen, S., Betts, D. R., Ardle, L. M., Gorman, K. M., King, M. D., et al. (2018) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2018.07.015 · Cited by 78
Genome-wide association study meta-analysis of suicide death and suicidal behavior
Li, Q. S., Shabalin, A. A., DiBlasi, E., Gopal, S., Canuso, C. M., FinnGen, I. S. G. C., Palotie, A., Drevets, W. C., Docherty, A. R., & Coon, H. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01828-9 · Cited by 68
Ferrari, R., Grassi, M., Salvi, E., Borroni, B., Palluzzi, F., Pepe, D., D’Avila, F., Padovani, A., Archetti, S., Rainero, I., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.005 · Cited by 68
Molecular Mechanism of MDGA1: Regulation of Neuroligin 2:Neurexin Trans-synaptic Bridges
Gangwar, S. P., Zhong, X. S., Seshadrinathan, S., Chen, H., Machius, M., & Rudenko, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.009 · Cited by 68
The neurodevelopmental spectrum of synaptic vesicle cycling disorders
John, A., Ng‐Cordell, E., Hanna, N., Brkić, D., & Baker, K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15135 · Cited by 65
Phenotypic spectrum of NRXN1 mono‐ and bi‐allelic deficiency: A systematic review
Castronovo, P., Baccarin, M., Ricciardello, A., Picinelli, C., Tomaiuolo, P., Cucinotta, F., Frittoli, M., Lintas, C., Sacco, R., & Persico, A. M. (2020) · Clinical Genetics · doi:10.1111/cge.13537 · Cited by 65
Drosophila models of early onset cognitive disorders and their clinical applications
van der Voet, M., Nijhof, B., Oortveld, M. A. W., & Schenck, A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.013 · Cited by 68
Disorders and borders: Psychiatric genetics and nosology
Smoller, J. W. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32174 · Cited by 68
Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging
Jenkins, A. K., Paterson, C., Wang, Y., Hyde, T. M., Kleinman, J. E., & Law, A. J. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.107 · Cited by 66
Gokhale, A., Hartwig, C. L., Freeman, A. A. H., Bassell‐Hawkins, J., Zlatic, S. A., Savas, C. S., Vadlamudi, T., Abudulai, F., Pham, T. T., Crocker, A. J., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1983-18.2019 · Cited by 61
Calsyntenin-3 Molecular Architecture and Interaction with Neurexin 1α
Lu, Z., Wang, Y., Chen, F., Tong, H., Reddy, M., Luo, L., Seshadrinathan, S., Zhang, L., Holthauzen, L. M. F., Craig, A. M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.606806 · Cited by 57
Increased Ca2+ signaling in NRXN1α+/− neurons derived from ASD induced pluripotent stem cells
Avazzadeh, S., McDonagh, K., Reilly, J., Wang, Y., Boomkamp, S. D., McInerney, V., Krawczyk, J., Fitzgerald, J., Feerick, N., O’Sullivan, M., et al. (2019) · Molecular Autism · doi:10.1186/s13229-019-0303-3 · Cited by 57
Genetics and the Language Sciences
Fisher, S. E., & Vernes, S. C. (2014) · Annual Review of Linguistics · doi:10.1146/annurev-linguist-030514-125024 · Cited by 55
Nazeen, S., Palmer, N., Berger, B., & Kohane, I. S. (2016) · Genome biology · doi:10.1186/s13059-016-1084-z · Cited by 55
Armstrong, E. C., Caruso, A., Servadio, M., Andreae, L. C., Trezza, V., Scattoni, M. L., & Fernandes, C. (2019) · Genes Brain & Behavior · doi:10.1111/gbb.12630 · Cited by 57
Lam, M., Moslem, M., Bryois, J., Pronk, R., Uhlin, E., Ellström, I. D., Laan, L., Olive, J. F., Morse, R., Rönnholm, H., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.06.014 · Cited by 50
Self-citationKalsner, L., Twachtman‐Bassett, J., Tokarski, K., Stanley, C. M., Dumont-Mathieu, T. M., Cotney, J. L., & Chamberlain, S. J. (2017) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.354 · Cited by 48
DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors
Chen, P., Liu, Z., Zhang, Q., Dong, L., Song, L., Liu, J., Jiao, H., Lai, X., Zou, S., Wang, S., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1003-21.2021 · Cited by 40
Incomplete penetrance of NRXN1 deletions in families with schizophrenia
Todarello, G., Feng, N., Kolachana, B. S., Li, C., Vakkalanka, R., Bertolino, A., Weinberger, D. R., & Straub, R. E. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.023 · Cited by 39
Cao, F., Liu, J. J., Zhou, S., Cortez, M. A., Snead, O. C., Han, J., & Jia, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-17560-3 · Cited by 43
O’Connor, E. C., Bariselli, S., & Bellone, C. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12510 · Cited by 40
A molecular model for neurodevelopmental disorders
Gigek, C. O., Chen, E., Ota, V., Maussion, G., Peng, H., Vaillancourt, K., Diallo, A., López, J. P., Crapper, L., Vasuta, C., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.56 · Cited by 38
Matsunami, N., Hensel, C. H., Baird, L. M., Stevens, J., Otterud, B., Leppert, M., Varvil, T., Hadley, D., Glessner, J., Pellegrino, R., et al. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-5 · Cited by 38
Li, Q., Wojciechowski, R., Simpson, C. L., Hysi, P. G., Verhoeven, V. J. M., Ikram, M. K., Höhn, R., Vitart, V., Hewitt, A. W., Oexle, K., et al. (2014) · Human Genetics · doi:10.1007/s00439-014-1500-y · Cited by 39
A common cognitive, psychiatric, and dysmorphic phenotype in carriers of NRXN1 deletion
Viñas‐Jornet, M., Esteba‐Castillo, S., Gabau, E., Ribas‐Vidal, N., Baena, N., San, J., Ruiz, A., Coll, M. D., Novell, R., & Guitart, M. (2014) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.105 · Cited by 39
New innovations: Therapeutic opportunities for intellectual disabilities
Picker, J. D., & Walsh, C. A. (2013) · Annals of Neurology · doi:10.1002/ana.24002 · Cited by 38
Nakamura, J., Gillespie, B., Gibbons, A. S., Jaehne, E. J., Du, X., Chan, A., Schroeder, A., van den Buuse, M., Sundram, S., & Hill, R. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.10.012 · Cited by 36
NRXN1α+/- is associated with increased excitability in ASD iPSC-derived neurons
Avazzadeh, S., Quinlan, L. R., Reilly, J., McDonagh, K., Jalali, A., Wang, Y., McInerney, V., Krawczyk, J., Ding, Y., Fitzgerald, J., et al. (2021) · BMC Neuroscience · doi:10.1186/s12868-021-00661-0 · Cited by 33
Liu, Y., Liang, Y., Çiçek, A. E., Li, Z., Li, J., Muhle, R., Krenzer, M., Mei, Y., Wang, Y., Knoblauch, N., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.03.023 · Cited by 34
Jenkins, A. K., Apud, J. A., Zhang, F., Decot, H., Weinberger, D. R., & Law, A. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.65 · Cited by 31
Meta-analysis of epigenome-wide association studies of major depressive disorder
Li, Q. S., Morrison, R. L., Turecki, G., & Drevets, W. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-22744-6 · Cited by 37
Vogel, J. W., Alexander-Bloch, A. F., Wagstyl, K., Bertolero, M. A., Markello, R. D., Pines, A., Sydnor, V. J., Diaz-Papkovich, A., Hansen, J. Y., Evans, A. C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219137121 · Cited by 34
Cooper, J. N., Mittal, J., Sangadi, A., Klassen, D. L., King, A. M., Zalta, M., Mittal, R., & Eshraghi, A. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072067 · Cited by 35
Rochtus, A. M., Trowbridge, S. K., Goldstein, R. D., Sheidley, B. R., Prabhu, S. P., Haynes, R. L., Kinney, H. C., & Poduri, A. (2019) · Molecular Case Studies · doi:10.1101/mcs.a003442 · Cited by 29
Copy number variants in neurexin genes: phenotypes and mechanisms
Fuccillo, M. V., & Pak, C. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.02.010 · Cited by 24
Rare copy number variants are common in young children with autism spectrum disorder
Eriksson, M. A., Liedén, A., Westerlund, J., Bremer, A., Wincent, J., Sahlin, E., Gillberg, C., Fernell, E., & Anderlid, B. (2015) · Acta Paediatrica · doi:10.1111/apa.12969 · Cited by 25
Self-citationThe clinical relevance of intragenic NRXN1 deletions
Cosemans, N., Vandenhove, L., Vogels, A., Devriendt, K., Esch, H. V., Buggenhout, G. V., Olivié, H., de Ravel, T. J. L., Ortibus, E., Legius, E., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106448 · Cited by 22
Bridging the translational gap: what can synaptopathies tell us about autism?
Molloy, C. J., Cooke, J., Gatford, N. J. F., Rivera-Olvera, A., Avazzadeh, S., Homberg, J. R., Grandjean, J., Fernandes, C., Shen, S., Loth, E., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1191323 · Cited by 23
Copy number variation in a hospital‐based cohort of children with epilepsy
Vlaskamp, D. R. M., Callenbach, P. M. C., Rump, P., Giannini, L., Dijkhuizen, T., Brouwer, O. F., & van Ravenswaaij‐Arts, C. M. A. (2017) · Epilepsia Open · doi:10.1002/epi4.12057 · Cited by 19
Self-citationRaciti, M., Salma, J., Spulber, S. D., Gaudenzi, G., Khalajzeyqami, Z., Conti, M., Anderlid, B., Falk, A., Hermanson, O., & Ceccatelli, S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00593 · Cited by 18
Self-citationSocial behavior in prepubertal neurexin 1α deficient rats: A model of neurodevelopmental disorders.
Kight, K. E., Argue, K. J., Bumgardner, J. G., Bardhi, K., Waddell, J., & McCarthy, M. M. (2021) · Behavioral Neuroscience · doi:10.1037/bne0000482 · Cited by 17
Agha, Z., Iqbal, Z., Azam, M., Siddique, M., Willemsen, M. H., Kleefstra, T., Zweier, C., de Leeuw, N., Qamar, R., & van Bokhoven, H. (2014) · Gene · doi:10.1016/j.gene.2014.01.027 · Cited by 16
Neurexin 1 variants as risk factors for suicide death
William, N., Reißner, C., Sargent, R., Darlington, T. M., DiBlasi, E., Li, Q. S., Keeshin, B. R., Callor, W. B., Ferris, E., Jerominski, L., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01190-2 · Cited by 15
Distinct neurexin isoforms cooperate to initiate and maintain foraging activity
Bastien, B. L., Cowen, M. H., & Hart, M. P. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02668-z · Cited by 14
Wang, J., Mahon, L. W., Ross, L. P., Anguiano, A. L., Owen, R. X., & Boyar, F. Z. (2016) · Molecular Cytogenetics · doi:10.1186/s13039-016-0291-3 · Cited by 14
Contemplating syndromic autism
Vorstman, J. A. S., & Scherer, S. W. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2023.100919 · Cited by 17
Characterization of speech and language phenotype in children with NRXN1 deletions
Brignell, A., John, M. S., Boys, A., Bruce, A., Dinale, C., Pigdon, L., Hildebrand, M. S., Amor, D. J., & Morgan, A. T. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32664 · Cited by 15
Bose, R., Posada-Pérez, M., Karvela, E., Škandík, M., Keane, L., Falk, A., Spulber, S. D., Joseph, B., & Ceccatelli, S. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.001 · Cited by 15
Yangngam, S., Plong-On, O., Sripo, T., Roongpraiwan, R., Hansakunachai, T., Wirojanan, J., Sombuntham, T., Ruangdaraganon, N., & Limprasert, P. (2014) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2014.0003 · Cited by 14
Wallis, M., Tsurusaki, Y., Burgess, T., Borzi, P., Matsumoto, N., Miyake, N., True, D., & Patel, C. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37478 · Cited by 13
Levy, K. A., Weisz, E. D., & Jongens, T. A. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac115 · Cited by 12
Çelebi, H. B. G., Bolat, H., & Ünsel‐Bolat, G. (2024) · Developmental Neurobiology · doi:10.1002/dneu.22941 · Cited by 13
The complex genetics in autism spectrum disorders
Hua, R., Wei, M., & Zhang, C. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4893-5 · Cited by 11
Alfieri, P., Scibelli, F., Sinibaldi, L., Valeri, G., Caciolo, C., Novello, R. L., Novelli, A., Digilio, M. C., Tartaglia, M., & Vicari, S. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12687 · Cited by 8
Association study between the neurexin‐1 gene and tardive dyskinesia
Lanning, R., Lett, T. A. P., Tiwari, A. K., Brandl, E. J., Luca, V. D., Voineskos, A. N., Potkin, S. G., Lieberman, J. A., Meltzer, H. Y., Müller, D. J., et al. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2568 · Cited by 7
Uzunhan, T. A., & Ayaz, A. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107141 · Cited by 6
Montalbano, S., Krebs, M. D., Rosengren, A., Vaez, M., Hellberg, K.-L. G., Mortensen, P. B., Børglum, A. D., Geschwind, D. H., iPSYCH Investigators, Hougaard, D. M., et al. (2024) · npj Genomic Medicine · doi:10.1038/s41525-024-00450-8 · Cited by 6
Feichtinger, R. G., Preisel, M., Brugger, K., Wortmann, S. B., & Mayr, J. A. (2023) · Genes · doi:10.3390/genes14061217 · Cited by 8
Rizzo, A., Alfei, E., Zibordi, F., Saletti, V., Zorzi, G. S., Freri, E., Estienne, M., Girgenti, V., D’Arrigo, S., Esposito, S., et al. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32649 · Cited by 6
NRXN1 Deletion in Two Twins’ Genotype and Phenotype: A Clinical Case and Literature Review
Sciacca, M., Marino, L., Vitaliti, G., Falsaperla, R., & Marino, S. (2022) · Children · doi:10.3390/children9050698 · Cited by 5
The Role of Inflammation in Autism Spectrum Disorder
Ferretti, C. J., & Hollander, E. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_14 · Cited by 5
Targeted splicing approach for alleviation of a neurexin 1 haploinsufficiency model
Lu, H. P., Roddick, K. M., Ge, Y., Zuo, L., Zhang, P., Lam, O., Marsh, K., Wong, R., Brown, R. E., & Craig, A. M. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03017-w · Cited by 5
Alpha-neurexins in health and disease
Chofflet, N., Wang, M., Chofflet, M., & Takahashi, H. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1716782 · Cited by 6
Guo, X., Wang, C., Long, D., Zhang, H., Yin, S., Peng, X., Liu, Y., Chen, S., Liu, Y., Huang, W., et al. (2025) · Epilepsia · doi:10.1111/epi.18337 · Cited by 4
Impact of copy number variants in epilepsy plus neurodevelopment disorders
João, S., Quental, R., Pinto, J., Almeida, C., Santos, H., & Dória, S. (2024) · Seizure · doi:10.1016/j.seizure.2024.01.009 · Cited by 4
Genetic mechanisms of neurodevelopmental disorders
Au, P. Y. B., Eaton, A. J., & Dyment, D. A. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64150-2.00024-1 · Cited by 5
Brownstein, C. A., Douard, E. A., Haynes, R. L., Koh, H. Y., Haghighi, A., Keywan, C., Martin, B. E., Alexandrescu, S., Haas, E. A., Vargas, S. O., et al. (2022) · Advanced Genetics · doi:10.1002/ggn2.202200012 · Cited by 4
Li, W., Xie, X., Chai, H., DiAdamo, A., Bistline, E. M., Li, P., Dai, Y., Knight, J., Avni-Singer, A. J., Burger, J., et al. (2025) · Genes · doi:10.3390/genes16080874 · Cited by 3
Delving into the Genetic Causes of Language Impairment in a Case of Partial Deletion of NRXN1
Benítez‐Burraco, A., Jiménez-Romero, M. S., & Fernández-Urquiza, M. (2022) · Molecular Syndromology · doi:10.1159/000524710 · Cited by 4
Rudolf, G., Lovrečić, L., Tul, N., Teran, N., & Peterlin, B. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.658 · Cited by 3
English, J., McSweeney, D., Geng, J., Howell, E., Ribbe, F., Hinderhofer, M., Proskauer, L., Sebastian, R., Wang, L., Sharf, T., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117115 · Cited by 3
Bayés, À., & Grant, S. G. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00006-6 · Cited by 3
Ding, Y., Howard, L., Gallagher, L., & Shen, S. (2015) · Frontiers in Biology · doi:10.1007/s11515-015-1363-1 · Cited by 2
The Molecular Convergence of Birdsong and Speech
Deshpande, M., & Lints, T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8400-4_6 · Cited by 2
Modeling Autism Spectrum Disorders Motor Deficits in Mice
Roubertoux, P. L., & Bartoli, C. (2014) · Neuromethods · doi:10.1007/978-1-4939-2250-5_15 · Cited by 1
NRXN1-related disorders, attempt to better define clinical assessment
Pavone, P., Pappalardo, X. G., Parano, C., Falsaperla, R., Corsello, A., Parano, E., Polizzi, A., & Ruggieri, M. (2024) · Open Medicine · doi:10.1515/med-2024-0979 · Cited by 1
Thalamic NRXN1-Mediated Input to Human Cortical Progenitors Drives Upper Layer NeurogenesisPreprint
Nguyen, C. V., Martija, A. A., Nano, P. R., Soto, J., Jaklic, D. C., Mil, J., White, R., Martín, J. M., Rana, D., Geschwind, D. H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650717 · Cited by 1
English, J., McSweeney, D., Geng, J., Howell, E., Ribbe, F., Hinderhofer, M., Proskauer, L., Sebastian, R., Wang, L., Sharf, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.18.664735 · Cited by 1
Allele-specific rescue of neurexin behavioral phenotypes by monoamine-targeting compoundsPreprint
Smisko, W. R., Haury, W. R., Perni, M., Kalik, R., Palo, J., Bastien, B. L., Bilchak, J. N., Khadour, R., Jongens, T. A., Kayser, M. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.06.703315 · Cited by 1
Genetic study of NRXN1β variants in Spanish patients with schizophrenia
Abasolo-Zabalo, N., Roig, B., Martorell, L., Martínez‐Leal, R., Aguilera, F., Camacho-Garcia, R. J., Orejuela, C., Scholl, F. G., Martı́nez-Mir, A., & Vilella, E. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.002
Metadata
- Authors
- Béna, F., Bruno, D. L., Eriksson, M., van Ravenswaaij‐Arts, C., Stark, Z., Dijkhuizen, T., Gerkes, E., Gimelli, S., Ganesamoorthy, D., Thuresson, A. C., Labalme, A., Till, M., Bilan, F., Pasquier, L., Kitzis, A., Dubourgm, C., Rossi, M., Bottani, A., Gagnebin, M., Sanlaville, D., Gilbert‐Dussardier, B., Guipponi, M., van Haeringen, A., Kriek, M., Ruivenkamp, C., Antonarakis, S. E., Anderlid, B. M., Slater, H. R., & Schoumans, J.
- Affiliations
- Royal Children's Hospital (AU)
- Karolinska Institutet (SE)
- University Medical Center Groningen (NL)
- University Hospital of Geneva (CH)
- Uppsala University (SE)
- Hospices Civils de Lyon (FR)
- Université de Poitiers (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Lyon 1 Université (FR)
- Leiden University Medical Center (NL)
- University of Geneva (CH)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Schoumans, Jacqueline
- ORCID
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2013-03-26
- Volume
- 162
- Issue
- 4
- Pages
- 388-403
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2053952465
- Cited by
- 109
- References
- 49
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 7 · 2019: 10 · 2018: 6 · 2017: 5 · 2016: 7 · 2015: 15 · 2014: 18 · 2013: 5
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- green
- research.rug.nl
- Licence
- Locations
- American Journal of Medical Genetics Part B Neuropsychiatric Genetics (publishedVersion)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- IRIS (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- NRXN1, exon deletion, haploinsufficiency, copy number variation, intellectual disability, language delay, autism spectrum disorder, seizures, hypotonia, phenotypic variability, neurodevelopmental disorders, head size
- MeSH terms
- Autistic Disorder, Calcium-Binding Proteins, Exons, Heterozygote, Humans, Karyotyping, Nerve Tissue Proteins, Seizures, Cohort Studies, Cell Adhesion Molecules, Neuronal, Sequence Deletion, Neural Cell Adhesion Molecules
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review